RACHEL ATLAS: Open Payments
NPI 1366854432 · EDISON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$548 in 33 payments from 9 companies in 2025. Trend: 2023 $334 · 2024 $572 · 2025 $548
Food & beverage: $548
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 7 | $112 |
| GlaxoSmithKline, LLC. | 5 | $80 |
| Viatris Specialty LLC | 4 | $69 |
| AstraZeneca Pharmaceuticals LP | 4 | $64 |
| Insmed, Inc. | 4 | $62 |
| Grifols USA, LLC | 3 | $56 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $47 |
| Philips North America LLC | 2 | $37 |
| Mallinckrodt Hospital Products Inc. | 1 | $21 |
Products named: TEZSPIRE, YUPELRI, NUCALA, Arikayce, Prolastin-C Liquid, JASCAYD, FASENRA, Vest Therapy Und.
Industry payments across NJ — which companies pay providers there.
